Arterial hypertension: A cause of cognitive impairment and of vascular dementia

Clinical and Experimental Hypertension

Volumn 26, Issue 4, 2004, Pages 277-285

  Paglieri, Cristina ^a   Bisbocci, Daniela ^a   Di Tullio, Maria Antonietta ^b   Tomassoni, Daniele ^b   Amenta, Francesco ^b   Veglio, Franco ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF CAMERINO   (Italy)

Author keywords

Arterial hypertension; Cerebral infarction; Cerebrovascular disease; Cognitive impairment and dementia; Intracerebral hemorrhage

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CANDESARTAN; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; FELODIPINE; ISRADIPINE; LISINOPRIL; LOSARTAN; MANIDIPINE; NICARDIPINE; NITRENDIPINE; PERINDOPRIL; VALSARTAN;

ANTIHYPERTENSIVE ACTIVITY; BRAIN HEMORRHAGE; BRAIN INFARCTION; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; CONFERENCE PAPER; CONSULTATION; DRUG EFFECT; DRUG EFFICACY; EARLY DIAGNOSIS; HIGH RISK PATIENT; HUMAN; HYPERTENSION; MULTIINFARCT DEMENTIA; RISK ASSESSMENT; RISK FACTOR;

COGNITION DISORDERS; DEMENTIA, VASCULAR; HUMANS; HYPERTENSION;

EID: 2542467973     PISSN: 10641963     EISSN: None     Source Type: Journal    
DOI: 10.1081/CEH-120034134     Document Type: Conference Paper

References (41)

1. Goldstein LB, Adams R, Becker K, Furberg CD, Gorelick PB, Hademenos G, Hill M, Howard VJ, Jacobs B, Levine SR, Mosca L, Sacco RL, Sherman DG, Wolf PA, Del Zoppo GJ. Primary prevention of ischemic stroke: a statement for healthcare professionals from the Stroke Council of the American Heart Association. Stroke January 2001; 32:280-299.
2. Burt VL, Culter JA, Higgins M, et al. Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population: data from the Health Examination Surveys, 1960 to 1991. Hypertension 1995; 26:60-69.
3. Klungel OH, Stricker BH, Paes AH, Seidell JC, Bakker A, Vok Z, Breteler MM, De Boer A. Excess stroke among hypertensive men and women attributable to undertreatment of hypertension. Stroke 1999; 30:1312-1318.
4. Frishman WH. Are antihypertensive agents protective against dementia? A review of clinical and preclinical data. Heart Dis 2002; 4(6):380-386.
5. Manolio TA, Olson J, Longstreth WT. Hypertension and cognitive function: pathophysiologic effects of hypertension on the brain. Curr Hypertens Rep 2003; 5:255-261.
6. Cervilla JA, Prince M, Joels S, Lovestone S, Mann A. Long-term predictors of cognitive outcome in a cohort of older people with hypertension. Br J Psychiatry 2000; 177:66-71.
7. Birkenhäger WH, Forette F, Seux ML, Wang JG, Staessen JA. Blood pressure, cognitive functions, and prevention of dementias in older patients with hypertension. Arch Intern Med 2001; 161:152-156.
8. Forette F, Boller F. Hypertension and the risk of dementia in the elderly. Am J Med 1991; 90:14S-19S.
9. Roman GC. Vascular dementia: distinguishing characteristics treatment, and prevention. J Am Geriat Soc 2003; 51:S296-S304.
10. O'Brien JT, Erkinjuntti T, Reisberg B, Roman G, Sawada T, Pantoni L, Bowler JV, Ballard C, De Carli C, Gorelick PB, Rockwood K, Burns A, Gauthier S, Dekosky ST. Vascular cognitive impairment. Lancet Neurol 2003; 2(2):89-98.
11. Erkinjunti T. Cognitive decline and treatment options for patients with vascular dementia. Acta Neurol Scand 2002; 106:15-18.
12. Wentzel C, Rockwood K, Macknight C. Progression of impairment in patients with vascular cognitive impairment without dementia. Neurology 2001; 57:714-716.
13. Harrington F, Saxby BK, Mckeith JG, Wesnes K, Ford GA. Cognitive performance in hypertensive and normotensive older subjects. Hypertension 2000; 36:1079-1082.
14. IDB Population Parameters. U.S. Census Bureau: Washington, 2002.
15. The Italian Longitudinal Study on Aging Working Group. Prevalence of chronic diseases in older Italians: comparing self-reported and clinical diagnoses. Int J Epidemiol 1997; 26:995-1002.
16. Di Carlo A, Baldereschi M, Amaducci L, Lepore V, Bracco L, Maggi S, Bonaiuto S, Perissinotto E, Scarlato G, Farchi G, Inzitari D, ILSA Working Group. Incidence of dementia, Alzheimer's disease, and vascular dementia in Italy. The ILSA study. J Am Geriatr Soc 2002; 50:41-48.
17. Farmer ME, Kittner SJ, Abbott RD, Wolz MM, Wolf PA, White LR. Longitudinally measured blood pressure, antihypertensive medication use, and cognitive performance: the Framingham study. J Clin Epidemiol 1990; 43:475-480.
18. Wong TY, Klein R, Sharrett R, Nieto FJ, Boland LL, Couper DJ, Mosley TH, Klein BEK, Hubbard LD, Szklo M. Retinal microvascular abnormalities and cognitive impairment in middle-aged persons. The atherosclerosis risk in communities study. Stroke 2002; 33:1487-1492.
19. Tomassoni D, Mancinelli, G, Mignini F, Sabbatini M, Amenta F. Quantitative image analysis of choroid and retinal vasculature in SHR: a model of cerebrovascular hypertensive-changes? Clin Exp Hypertens 2002; 24:741-752.
20. De Leeuw FE, De Kleine M, Frijns CJM, Fijnheer R, Van Gijn J, Cappelle LJ. Endothelial cell activation is associated with cerebral white matter lesions in patients with cerebrovascular disease. Ann NY Acad Sci 2002; 977:306-314.
21. Shimada K, Kawamoto A, Matsubayashi K, Ozawa T. Silent cerebrovascular disease in the elderly correlation with ambulatory pressure. Hypertension 1990; 16:692-699.
22. Fukuda H, Kitani M. Differences between treated and untreated hypertensive subjects in the extent of periventricular hyperintensities observed on brain MRI. Stroke 1995; 26:1593-1597.
23. Shimada K, Kawamoto A, Matsubayashi K, Nishinaga M, Kimura S, Ozawa T. Diurnal blood pressure variations and silent cerebrovascular damage in elderly patients with hypertension. J Hypertens 1992; 10:875-878.
24. Kario K, Mtsuo T, Kobayashi H, Imiya M, Matsuo M, Shimada K. Nocturnal fall of blood pressure and silent cerebrovascular damage in elderly hypertensive patients. Advanced silent cerebrovascular damage in extreme dippers. Hypertension 1996; 27:130-135.
25. Miyao S, Takano A, Teramoto J, Takahashi A. Leukoaraiosis in relation to prognosis for patient with lacunar infarction. Stroke 1992; 23:1434-1438.
26. Van Swieten JC, Kapelle LJ, Algra A, Van Latum JC, Koudstaal PJ, Van Gijn J. Hypodensity of the cerebral white matter in patients with transient ischemic attack or minor stroke: influence on the rate of subsequent stroke. Dutch TIA trial study group. Ann Neurol 1992; 32:177-183.
27. Inzitari D, Di Carlo A, Mascalchi M, Pracucci G, Amaducci L. The cardiovascular outcome of patients with motor impairment and estensive leukoaraiosis. Arch Neurol 1995; 52:687-691.
28. Bigler ED, Kerr B, Victoroff J, Tafe DF, Breitner JC. White matter lesions, quantitative magnetic resonance imaging, and dementia. Alzheimer Dis Assoc Disord 2002; 16:161-170.
29. Dufouil C, Alpérovitch A, Tzourio C. Influence of education on the relationship between white matter lesions and cognition. Neurology 2003; 60:831-836.
30. Sierra C, De La Sierra A, Mercader J, Gòmez-Angelats E, Urbano-Màrquez A, Coca A. Silent cerebral white matter lesions in middle-aged essential hypertensive patients. J Hypertens 2002; 20:519-524.
31. Kobayashi S. Subcortical silent brain infarction as a risk factor for clinical stroke. Stroke 1997; 28:1932-1939.
32. Vermeer S, Prins ND, Den Heijer T, Hofman A, Koudstaal PJ, Breteler MMB. Silent brain infarcts and the risk of dementia and cognitive decline. NEJM 2003; 348:1215-1222.
33. Shinkawa A. Silent cerebral infarction in a community-based autopsy series in Japan. The Hisayama study. Stroke 1995; 26:380-385.
34. Swan GE, Decarli C, Mileer BL. Association of midlife blood pressare to late-life cognitive decline and brain morphology. Neurology 1998; 51:986-993.
35. Ballard C, O'Brien J, Morris CM. The progression of cognitive impairment in dementia with Lewy bodies, vascular dementia and Alzheimer's disease. Int J Geriatr Psychiatry 2001; 16:499-503.
36. Folstein MF, Folstein SE, Mchugh PR. "Mini-mental state." A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12:189-198.
37. Amenta F, Mignini F, Rabbia F, Tomassoni D, Veglio F. Protective effect of antihypertensive treatment on cognitive function in essential hypertension: analysis of published clinical data. J Neurol Sci 2002; 203-204:147-151.
38. Lithell H, Hansson L, Skoog I, Elmfeldt D, Hofman A, Olofsson B, Trenkwalder O, Zanchetti A. The study on cognition and prognosis in the elderly (SCOPE): principal results of a randomized double-blind interventional trial. J Hypertens 2003; 21:875-886.
39. In't Veld BA, Ruitenberg A, Hofman A, Stricker BH, Breteler MM. Antihypertensive drugs and incidence of dementia: the Rotterdam study. Neurobiol Aging 2001; 22:407-412.
40. Tedesco MA, Ratti G, Mannella S, Manzo G, Greco M, Rainone AC. Comparison of losartan and hydrochlorothiazide on cognitive function and quality of life in hypertensive patients. Am J Hypertens 1999; 12:1130-1134.
41. Franz IW. AT1 receptor antagonists in treatment of hypertension. Fortschr Med 1997; 115:38-40.